Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor
- 31 March 2005
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 112 (3) , 466-469
- https://doi.org/10.1016/j.ophtha.2004.09.029
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolatesAmerican Journal of Ophthalmology, 2003
- Recent Advances and Future Frontiers in Treating Age-Related CataractsJAMA, 2003
- Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit modelAmerican Journal of Ophthalmology, 2003
- Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics11The Eye and Ear Foundation of Pittsburgh (Pittsburgh, PA) was given a core grant for Vision Research EY 08098 and Research to Prevent Blindness. The first author (R.M.) was granted travel support for ARVO 2001 in Fort Lauderdale, FL by Alcon (Fort Worth, TX).American Journal of Ophthalmology, 2002
- Activity of gatifloxacin against strains resistant to ofloxacin and ciprofloxacin and its ability to select for less susceptible bacterial variantsInternational Journal of Antimicrobial Agents, 2001
- FluoroquinolonesDrugs, 2001
- Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolonesOphthalmology, 2000
- Emerging ciprofloxacin-resistant Pseudomonas aeruginosaAmerican Journal of Ophthalmology, 1999
- Mechanisms of fluoroquinolone resistanceDrug Resistance Updates, 1999
- Results of the Endophthalmitis Vitrectomy StudyArchives of Ophthalmology (1950), 1995